HSP90B1 and central nervous system cancer: By analyzing public databases, including TCGA, CGGA, Rembrandt[20], and Gravendeel[21], we found that the high expression level of HSP90B1 was associated with the reduced overall survival rate of glioma patients (Fig. 1D andSupplementary Fig. 2B [available online]).